RE: RNS news11 Mar 2022 10:19
Regulator: I agree with you on CD4, has a future but my investment was due to a £374 million contract in the middle of a pandemic, CD4 would be the cherry. Instead of that I've actually invested in a BOD who do not seem accou table, spent money on expanding Alva, pursuing lft but not doing due diligence or having the ability to read while at the same time sucking the life blood out of the company with salaries not commensurate with the performance of the company. This latest RNS beggers belief!!!!
IMHO stopping the placing, open offer and directors entitlements was imperative. The BOD spent £8 million (?) On ALVA and got SF All back and then want more money! PLEASE!!! They will have to WORK on the issues with no money unless they would like to chip in. How much have they got in the company? Exactly!!!! Bugger all, probably less than the losses being carried by many shareholders.
Ranting, yes a little!